Streetbeat News

Earnings

CURV

Torrid Holdings (NYSE:CURV) reported Q4 2024 earnings with a smaller loss per share of $(0.04) compared to the estimated $(0.07), and sales of $293.5M, surpassing the $274.827M estimate.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 8:09 pm

SHCR

Sharecare reported Q4 adjusted EPS of $(0.03), beating the $(0.06) estimate, but missed sales estimates with $105.28M against the expected $114.99M. Year-over-year, EPS decreased by 50% and sales by 14.59%.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 8:08 pm

SRFM

Surf Air Mobility reported Q4 revenue of $26.8M and pro forma revenue of $27.4M, surpassing the $25.69M estimate. FY23 EPS was $(6.35), compared to $(5.51) year-over-year, with annual revenue reaching $60.5M.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 8:07 pm

ELDN

Eledon Pharma (NASDAQ:ELDN) reported a Q4 2023 GAAP EPS loss of $(0.32), surpassing the analyst consensus estimate of $(0.39) by 17.95%.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 8:07 pm

SRFM

Surf Air Mobility reported an expected Q1 revenue of $28.5M-$29.5M, falling short of the estimated $32.3M.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 8:06 pm

SRFM

Surf Air Mobility's CFO, Oliver Reeves, outlines the company's strategy for 2024, focusing on growth, profitability, expense reduction, and disciplined capital allocation. This includes exploring high ROI opportunities and potential route expansions.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 8:06 pm

DNMR

Danimer Scientific projects an improvement in operating margins and operating cash flow throughout the year.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 8:02 pm

DNMR

Danimer Scientific (DNMR) reported Q4 2023 GAAP EPS of $(0.39), missing the $(0.38) estimate, with sales of $10.900M also missing the $11.333M estimate. This represents a 28.87% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 8:02 pm

CVV

CVD Equipment (NASDAQ:CVV) reported a significant decrease in both earnings and sales for Q4, with EPS at $(0.33), down from $0.23 YoY, and sales at $4.11M, down from $7.23M YoY.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 8:01 pm

EQIX

In the past three months, 12 analysts have provided diverse ratings for Equinix (NASDAQ:EQIX), with sentiments ranging from bullish to bearish. The average 12-month price target for EQIX has been raised to $816.42, up 7.71% from the previous target. Analyst actions include adjustments to ratings and price targets, reflecting their evolving views on Equinix's market position. Equinix, operating as a REIT, has shown significant revenue growth but faces challenges in profitability and efficiency metrics compared to industry averages.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 8:00 pm